Jefferies downgrades Opko Health stock to Hold on flat Ngenla sales
NegativeFinancial Markets

Jefferies has downgraded Opko Health's stock to a 'Hold' rating due to stagnant sales of its Ngenla product. This decision reflects concerns about the company's growth potential and market performance, which could impact investor confidence and stock value. Understanding these shifts is crucial for stakeholders as they navigate the complexities of the healthcare market.
— Curated by the World Pulse Now AI Editorial System










